Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE).

Abdulahad DA, Westra J, Reefman E, Zuidersma E, Bijzet J, Limburg PC, Kallenberg CG, Bijl M.

Lupus. 2013 May;22(6):597-606. doi: 10.1177/0961203313483377. Epub 2013 Apr 2.

PMID:
23549344
[PubMed - indexed for MEDLINE]
2.

Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.

Abdulahad DA, Westra J, Bijzet J, Dolff S, van Dijk MC, Limburg PC, Kallenberg CG, Bijl M.

Arthritis Res Ther. 2012 Aug 14;14(4):R184. [Epub ahead of print]

PMID:
22892043
[PubMed - as supplied by publisher]
Free PMC Article
3.

High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.

Abdulahad DA, Westra J, Bijzet J, Limburg PC, Kallenberg CG, Bijl M.

Arthritis Res Ther. 2011 May 6;13(3):R71. doi: 10.1186/ar3332.

PMID:
21548924
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development.

Abdulahad DA, Westra J, Limburg PC, Kallenberg CG, Bijl M.

Autoimmun Rev. 2010 Aug;9(10):661-5. doi: 10.1016/j.autrev.2010.05.015. Epub 2010 May 21. Review.

PMID:
20546955
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk